Empowering Cell & Gene Therapy with AI
LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
CytoHub proudly welcomes Aitor Aguirre, Ph.D., a distinguished Associate Professor from Michigan State University, as our new Scientific Advisor. His expertise will propel our AI-driven therapeutic innovations to new heights.
CytoHub welcomes Frank Teoh as Vice President, Global Head of BioEngineAI Platform, bringing over two decades of engineering leadership and innovation. With achievements that include $100M+ in business impact and 9 patents, Frank’s expertise will steer CytoHub to new frontiers in AI-driven therapeutics.
David is a renowned Venture Investor, Investment Banker, and Mentor, known for assisting healthcare and life sciences entrepreneurs. His appointment significantly bolsters our Advisory Board’s strength, promising valuable insights and strategic direction for CytoHub’s growth.